St. Petersburg, FL, United States of America

Yuka Tamura

This inventor holds 1 USPTO granted patent. Top assignee: Kaken Shoyaku Co., Ltd.. Active years: 1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yuka Tamura. Retrieved from https://idiyas.com/inventor/yuka-tamura-utv9n1pb

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yuka Tamura: Innovator in Anti-AIDS Virus Composition

Introduction

Yuka Tamura is a prominent inventor based in St. Petersburg, FL (US). She has made significant contributions to the field of medical science, particularly in the development of treatments for viral infections.

Latest Patents

Yuka Tamura holds 1 patent for her innovative work on an anti-AIDS virus composition. This patent discloses a composition comprising a therapeutically effective amount of cepharanthine or a pharmaceutically acceptable salt thereof. The method for treating AIDS involves administering a therapeutically effective amount of cepharanthine or a pharmaceutically acceptable salt thereof.

Career Highlights

Tamura's career is marked by her dedication to advancing medical treatments. She works at Kaken Shoyaku Co., Ltd., where she collaborates with other talented professionals in the field. Her work has the potential to impact the lives of many individuals affected by AIDS.

Collaborations

Some of her notable coworkers include Minoru Ono and Michinori Akasu. Their collective expertise contributes to the innovative environment at Kaken Shoyaku Co., Ltd.

Conclusion

Yuka Tamura's contributions to the field of medical science, particularly in the development of anti-AIDS treatments, highlight her role as a significant inventor. Her work continues to inspire advancements in healthcare and treatment options for viral infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…